Yonatan Kok
7PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 24, 2021
The impact of incomplete clinical information and initial biopsy technique on the histopathological diagnosis of cutaneous melanoma.Yonatan Kok, Karen Scott, Alan Pham
|Jun 03, 2021
Comparison of the EUROIMMUN Dermatology Profile ELISA to the novel BIOCHIP Mosaic 7 for the diagnosis of immunobullous skin disease.Kate Simpson, Laura Scardamaglia, Yonatan Kok
|Mar 17, 2021
Tildrakizumab as a potential long-term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institution.Yonatan Kok, Jenny Nicolopoulos, Con Dolianitis
|Jul 07, 2020
Tildrakizumab in the treatment of moderate-to-severe hidradenitis suppurativa.Yonatan Kok, Jenny Nicolopoulos, Anne Howard
|Apr 15, 2020
Tildrakizumab in the treatment of PASH syndrome: A potential novel therapeutic target.Yonatan Kok, Jenny Nicolopoulos, George Varigos
|Feb 18, 2020
Measuring treatment response to adalimumab in hidradenitis suppurativa patients: An observational study.Yonatan Kok, Jenny Nicolopoulos, Anna Braue
Pageof 2
